- |||||||||| olanzapine / Generic mfg., clozapine / Generic mfg.
Enrollment change, Adverse events: Alleviating the Metabolic Side Effects of Antipsychotic Medications (clinicaltrials.gov) - Apr 24, 2019 P4, N=0, Withdrawn, Completed --> Active, not recruiting | Trial completion date: Jul 2012 --> Jul 2024 | Trial primary completion date: Jul 2012 --> Jul 2023 N=90 --> 0
- |||||||||| aripiprazole / Generic mfg.
Enrollment change: Validation of Receptor Occupancy Simulation (clinicaltrials.gov) - Apr 20, 2019 P=N/A, N=7, Completed, Active, not recruiting --> Completed | Trial completion date: Apr 2020 --> Apr 2019 N=20 --> 7
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Cross-Sectional Iloperidone IVGTT (clinicaltrials.gov) - Mar 12, 2019
P=N/A, N=37, Completed, Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 37 | Trial completion date: Dec 2015 --> May 2016 | Trial primary completion date: Dec 2015 --> May 2016
- |||||||||| olanzapine / Generic mfg., sertraline / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) - Mar 5, 2019 P4, N=269, Completed, Recruiting --> Completed | N=60 --> 37 | Trial completion date: Dec 2015 --> May 2016 | Trial primary completion date: Dec 2015 --> May 2016 Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Nov 2017 | Trial primary completion date: Mar 2018 --> Nov 2017
- |||||||||| Trial completion: Cognitive Remediation and Sheltered Employment in Schizophrenia (clinicaltrials.gov) - Feb 25, 2019
P=N/A, N=79, Completed, Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Nov 2017 | Trial primary completion date: Mar 2018 --> Nov 2017 Active, not recruiting --> Completed
- |||||||||| Trial completion: Remote Cognitive Remediation (clinicaltrials.gov) - Nov 15, 2018
P=N/A, N=100, Completed, Trial completion date: Dec 2012 --> Jun 2017 Recruiting --> Completed
- |||||||||| olanzapine / Generic mfg., sertraline / Generic mfg.
Trial completion date, Trial primary completion date: STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) - Sep 17, 2018 P4, N=269, Active, not recruiting, Active, not recruiting --> Completed | Trial completion date: Dec 2016 --> Jun 2016 Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Mar 2018
- |||||||||| Clinical data, Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis (clinicaltrials.gov) - Aug 27, 2018
P=N/A, N=88, Completed, N=30 --> 15 | Recruiting --> Terminated; Failure to recruit the planned number of participants Suspended --> Completed | N=264 --> 88 | Trial completion date: Mar 2019 --> Jul 2018 | Trial primary completion date: Mar 2019 --> Jul 2018
- |||||||||| Trial completion: Reducing the Weight of Overweight Schizophrenia Patients (clinicaltrials.gov) - Aug 22, 2018
P=N/A, N=261, Completed, Suspended --> Completed | N=264 --> 88 | Trial completion date: Mar 2019 --> Jul 2018 | Trial primary completion date: Mar 2019 --> Jul 2018 Active, not recruiting --> Completed
- |||||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
Trial termination: Linagliptin in Schizophrenia Patients (clinicaltrials.gov) - Aug 16, 2018 P1, N=1, Terminated, Phase classification: P3 --> P=N/A Suspended --> Terminated; Inability to obtain patients
- |||||||||| metformin / Generic mfg.
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness (clinicaltrials.gov) - Jul 30, 2018 P4, N=35, Completed, N=18 --> 12 | Recruiting --> Terminated; low enrollment due to limited resources Recruiting --> Completed | N=24 --> 35 | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Feb 2018
- |||||||||| Trial completion, Phase classification: Study of Vitamin D in the Severely Mentally Ill (clinicaltrials.gov) - Jul 19, 2018
P4, N=40, Completed, Recruiting --> Completed | N=24 --> 35 | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Feb 2018 Active, not recruiting --> Completed | Phase classification: PN/A --> P4
- |||||||||| tolcapone / Generic mfg.
Trial termination: Clinical Trial of Tolcapone for Cognition in Schizophrenia (clinicaltrials.gov) - Jul 17, 2018 P2, N=210, Terminated, Active, not recruiting --> Completed | Phase classification: PN/A --> P4 Completed --> Terminated; Scientific Director request to use resources for other studies
- |||||||||| Trial completion, Enrollment change: Home Treatment for Acute Psychiatric Care (clinicaltrials.gov) - Jun 6, 2018
P=N/A, N=707, Completed, N=48 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | N=500 --> 707
- |||||||||| Trial completion: Exercise and Cognitive Training (clinicaltrials.gov) - Jun 4, 2018
P=N/A, N=30, Completed, Recruiting --> Completed | N=500 --> 707 Active, not recruiting --> Completed
- |||||||||| Trial completion, Enrollment change, Trial completion date: Social Cognition Training in Schizophrenia (clinicaltrials.gov) - Jun 2, 2018
P=N/A, N=48, Completed, Active, not recruiting --> Completed Recruiting --> Completed | N=25 --> 48 | Trial completion date: Dec 2018 --> May 2018
- |||||||||| clozapine / Generic mfg.
Trial completion, Enrollment change, Adverse events: Metabolic Side-effects for Second-generation Antipsychotics (clinicaltrials.gov) - May 3, 2018 P=N/A, N=241, Completed, Phase classification: P=N/A --> P3 | N=18 --> 30 Recruiting --> Completed | N=372 --> 241
|